Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer
Author:
Funder
The Norwegian and Swedish Cancer Societies and the Danish Colorectal Cancer Group
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/24/9/2354/13789904/mdt197.pdf
Reference21 articles.
1. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin and oxaliplatin (Nordic FLOX) versus FLOX alone in firstline treatment of metastatic colorectal cancer: The NORDIC-VII study;Tveit;J Clin Oncol,2012
2. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy;Kopetz;J Clin Oncol,2009
3. Significant improvement in survival of patients presenting with metastatic colon cancer in the south of the Netherlands from 1990 to 2004;Meulenbeld;Ann Oncol,2008
4. Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992–2008;Lemmens;Clin Exp Metastasis,2011
5. Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in the Netherlands 1989–2006;van Steenbergen;Ann Oncol,2010
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Real-Life Impact of mFOLFIRI-Based Chemotherapies on Elderly Patients—Should We Let It or Leave It?;Cancers;2023-10-26
2. Prognostic model for predicting the survival benefit of adjuvant chemotherapy for elderly patients with stage II colon cancer: a population-based study;European Journal of Cancer Prevention;2023-08-25
3. The extracellular matrix – immune microenvironment crosstalk in cancer therapy: Challenges and opportunities;Matrix Biology;2023-08
4. Construction and validation of a prognostic nomogram for predicting cancer-specific survival in patients with intermediate and advanced colon cancer after receiving surgery and chemotherapy;Journal of Cancer Research and Clinical Oncology;2023-07-17
5. First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study);Frontiers in Medicine;2023-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3